Business · 26/02/1996
FDA Releases Draft Document on Regulation of Placental/Umbilical Cord Blood Stem Cell Products
The FDA is releasing a draft document outlining its approach to regulating placental/umbilical cord blood stem cell products for transplantation, inviting public comments on the proposal.